Assignee
SELECTIMMUNE PHARMA AB
SE·2 granted patents·4 pending applications·0 citations·filing 2016–2024
Top patents by PatentIndex Score
6 records- 0159US2025082625A1Novel therapySELECTIMMUNE PHARMA AB·Filed 2024·Application pending·0 cites
- 0251US2021252107A1Novel therapySELECTIMMUNE PHARMA AB·Filed 2021·Application pending·0 cites
- 0351US2025241990A1Therapeutic agentSELECTIMMUNE PHARMA AB·Filed 2023·Application pending·0 cites
- 0450US11752192B2Inhibitor of RNA polymerase IISELECTIMMUNE PHARMA AB·Filed 2020·Granted Sep 12, 2023·0 cites·15 claims
- 0548US11013786B2TherapySELECTIMMUNE PHARMA AB·Filed 2016·Granted May 25, 2021·0 cites·7 claims
- 0643US2022252625A1Treatment and diagnosis of chronic inflammatory conditions in the lower urinary tractSELECTIMMUNE PHARMA AB·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SELECTIMMUNE PHARMA AB files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →